Decoy Therapeutics Inc. (DCOY)
US — Healthcare Sector
Automate Your Wheel Strategy on DCOY
With Tiblio's Option Bot, you can configure your own wheel strategy including DCOY - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowNews
Decoy Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
DCOY
Published: February 05, 2026 by: PRNewsWire
Sentiment: Neutral
Published: February 05, 2026 by: PRNewsWire
Sentiment: Neutral
– Live video webcast on Tuesday, February 10th at 1:20 PM EST CAMBRIDGE, Mass. and HOUSTON, Feb. 5, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), a preclinical biopharmaceutical that is engineering the next generation of peptide conjugate therapeutics, today announced that it will participate in the Corporate Connect Webinar Series hosted by Webull Financial being held virtually February 10-11, 2026.
Read More
About Decoy Therapeutics Inc. (DCOY)
- IPO Date 2015-01-29
- Website https://decoytx.com
- Industry Biotechnology
- CEO Frederick E. Pierce
- Employees 2
Decoy Therapeutics, Inc. is a preclinical-stage biotechnology company that is leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The company is headquartered in Cambridge, MA.